BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21569715)

  • 1. [Analysis of clinical features and prognostic significance of CD20 positive childhood precursor B-lineage acute lymphoblastic leukemia].
    Nie SS; Zhao WL; Ji ZH
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):275-7. PubMed ID: 21569715
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical evaluation of prognostic factors in childhood acute lymphoblastic leukemia.
    Derulska D; Rokicka-Milewska R; Lewicki Z
    J Chemother; 1989 Jul; 1(4 Suppl):1273-5. PubMed ID: 16312863
    [No Abstract]   [Full Text] [Related]  

  • 4. Retrospective review of pediatric patients with acute lymphoblastic leukemia: a single center experience.
    Khalid S; Moiz B; Adil SN; Khurshid M
    Indian J Pathol Microbiol; 2010; 53(4):704-10. PubMed ID: 21045397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
    Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
    Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
    Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
    BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
    Wiersma SR; Ortega J; Sobel E; Weinberg KI
    N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
    Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
    Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
    Thörn I; Forestier E; Botling J; Thuresson B; Wasslavik C; Björklund E; Li A; Lindström-Eriksson E; Malec M; Grönlund E; Torikka K; Heldrup J; Abrahamsson J; Behrendtz M; Söderhäll S; Jacobsson S; Olofsson T; Porwit A; Lönnerholm G; Rosenquist R; Sundström C
    Br J Haematol; 2011 Mar; 152(6):743-53. PubMed ID: 21250970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Jeha S; Behm F; Pei D; Sandlund JT; Ribeiro RC; Razzouk BI; Rubnitz JE; Hijiya N; Howard SC; Cheng C; Pui CH
    Blood; 2006 Nov; 108(10):3302-4. PubMed ID: 16896151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia.
    Spanaki A; Linardakis E; Perdikogianni C; Stiakaki E; Morotti A; Cilloni D; Kalmanti M
    Leuk Res; 2007 Apr; 31(4):570-2. PubMed ID: 16876863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and treatment of acute lymphoblastic leukaemia (ALL)--Istanbul experience.
    Gedikoğlu G
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():18. PubMed ID: 2697393
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study.
    Horibe K; Hara J; Yagi K; Tawa A; Komada Y; Oda M; Nishimura S; Ishikawa Y; Kudoh T; Ueda K
    Int J Hematol; 2000 Jul; 72(1):61-8. PubMed ID: 10979211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia].
    Ma J; Sun H; Chen SM; Liu LX; Chen SQ; Liu YF; Xie XS; Meng XL; Deng M; Zhang QT; Li T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):477-81. PubMed ID: 20416193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow fibrosis and vascular density lack prognostic significance in childhood acute lymphoblastic leukaemia.
    Bharos A; Jong AJ; Manton N; Venn N; Story C; Hodge G; Nath S; Suppiah R; Tapp H; Sutton R; Revesz T
    Leukemia; 2010 Aug; 24(8):1537-8. PubMed ID: 20535149
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Buldini B; Zangrando A; Michielotto B; Veltroni M; Giarin E; Tosato F; Cazzaniga G; Biondi A; Basso G
    Am J Hematol; 2010 Feb; 85(2):138-41. PubMed ID: 20095033
    [No Abstract]   [Full Text] [Related]  

  • 20. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
    Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
    Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.